MA42246A - Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv - Google Patents

Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv

Info

Publication number
MA42246A
MA42246A MA042246A MA42246A MA42246A MA 42246 A MA42246 A MA 42246A MA 042246 A MA042246 A MA 042246A MA 42246 A MA42246 A MA 42246A MA 42246 A MA42246 A MA 42246A
Authority
MA
Morocco
Prior art keywords
variable domain
single variable
domain antibodies
immunoglobulin single
fusion immunoglobulin
Prior art date
Application number
MA042246A
Other languages
English (en)
Inventor
Morgan Gilman
Barney Graham
Jason Mclellan
Iebe Rossey
Xavier Saelens
Bert Schepens
Original Assignee
Us Health
Dartmouth College
Univ Gent
Vib Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57545045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA42246(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP15178653.0A external-priority patent/EP3124042A1/fr
Application filed by Us Health, Dartmouth College, Univ Gent, Vib Vzw filed Critical Us Health
Publication of MA42246A publication Critical patent/MA42246A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA042246A 2015-06-18 2016-06-20 Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv MA42246A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562181522P 2015-06-18 2015-06-18
EP15178653.0A EP3124042A1 (fr) 2015-07-28 2015-07-28 Anticorps à domaine variable unique contre la protéine f prefusion du virus respiratoire syncytial (rsv)
EP15191868 2015-10-28

Publications (1)

Publication Number Publication Date
MA42246A true MA42246A (fr) 2018-05-02

Family

ID=57545045

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042246A MA42246A (fr) 2015-06-18 2016-06-20 Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv

Country Status (18)

Country Link
US (2) US10501528B2 (fr)
EP (1) EP3313432A1 (fr)
JP (1) JP6836760B2 (fr)
KR (1) KR20180056631A (fr)
CN (1) CN108472343B (fr)
AU (1) AU2016277887B2 (fr)
BR (1) BR112017027303A2 (fr)
CA (1) CA2989378A1 (fr)
CL (1) CL2017003260A1 (fr)
HK (1) HK1254779A1 (fr)
IL (1) IL256315B2 (fr)
MA (1) MA42246A (fr)
MX (1) MX2017016590A (fr)
MY (1) MY192870A (fr)
PH (1) PH12017502356A1 (fr)
RU (1) RU2730671C2 (fr)
UA (1) UA123584C2 (fr)
WO (1) WO2016203052A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3313432A1 (fr) * 2015-06-18 2018-05-02 VIB vzw Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv
CN114835802B (zh) * 2019-08-02 2023-07-18 苏州高泓利康生物科技有限公司 针对呼吸道合胞病毒的蛋白结合分子
CN116063468A (zh) * 2022-08-30 2023-05-05 武汉班科生物技术有限公司 中和呼吸道合胞病毒的c-型单域抗体及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997830A1 (fr) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. Molécules à liaison spécifiques RSV et leur moyen de fabrication
PL2222710T3 (pl) * 2007-12-24 2017-01-31 Id Biomedical Corporation Of Quebec Rekombinowane antygeny rsv
DK2285408T3 (en) 2008-06-05 2019-02-04 Ablynx Nv AMINO ACID SEQUENCES AGAINST COATING PROTEINS IN A VIRUS AND POLYPEPTIDES INCLUDING THESE FOR TREATMENT OF VIRUSAL DISEASES
HUE035773T2 (en) * 2009-06-05 2018-05-28 Ablynx Nv Trivalent human airway giant cell virus (hrsv) nanotubes for preventing and / or treating respiratory infections
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
WO2011064382A1 (fr) * 2009-11-30 2011-06-03 Ablynx N.V. Séquences d'acides aminés améliorées dirigées contre le virus syncytial respiratoire humain (hrsv) et polypeptides comprenant celles-ci pour la prévention et/ou le traitement d'infections du tractus respiratoire
EP3313432A1 (fr) * 2015-06-18 2018-05-02 VIB vzw Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv

Also Published As

Publication number Publication date
CL2017003260A1 (es) 2018-05-11
BR112017027303A2 (pt) 2018-09-04
AU2016277887B2 (en) 2022-06-09
IL256315A (en) 2018-02-28
CN108472343B (zh) 2021-12-10
AU2016277887A1 (en) 2018-01-18
RU2018101662A (ru) 2019-07-22
US11248039B2 (en) 2022-02-15
MX2017016590A (es) 2018-11-09
CN108472343A (zh) 2018-08-31
UA123584C2 (uk) 2021-04-28
JP2018524979A (ja) 2018-09-06
PH12017502356B1 (en) 2018-06-25
IL256315B1 (en) 2023-08-01
WO2016203052A1 (fr) 2016-12-22
KR20180056631A (ko) 2018-05-29
US20180179266A1 (en) 2018-06-28
IL256315B2 (en) 2023-12-01
CA2989378A1 (fr) 2016-12-22
MY192870A (en) 2022-09-13
RU2018101662A3 (fr) 2019-11-06
RU2730671C2 (ru) 2020-08-24
HK1254779A1 (zh) 2019-07-26
JP6836760B2 (ja) 2021-03-03
EP3313432A1 (fr) 2018-05-02
US10501528B2 (en) 2019-12-10
PH12017502356A1 (en) 2018-06-25
US20200102374A1 (en) 2020-04-02

Similar Documents

Publication Publication Date Title
DK3809884T3 (da) Nikotinposeprodukt
MA52742A (fr) Anticorps bispécifiques dll3-cd3
DK3411410T3 (da) Pd-1-antistoffer
MA53297A (fr) Anticorps anti-icos
MA42626A (fr) Nouveaux anticorps anti-pd-1
MA49250A (fr) Nouveaux anticorps anti-cd3
MA50222A (fr) Anticorps bispécifiques anti-pd-l1-anti-tim-3
MA42246A (fr) Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv
DK3279312T3 (da) Biobeskyttelse af mejeriprodukter
MA41840A (fr) Anticorps bispécifiques anti-cd20 / anti-baff
UY4739S (es) Envase de fragancia
ES1231475Y (es) Bolsa de viaje
UA39246S (uk) Упаковка для косметичних засобів
TH1802002856S (th) บรรจุภัณฑ์
UA37982S (uk) Опакування
UA37594S (uk) Упаковка
UA38462S (uk) Упаковка
UA38715S (uk) Упаковка
UA38714S (uk) Упаковка
UA38163S (uk) Упаковка
UA38440S (uk) Опаковання
UA38434S (uk) Опаковання
UA38441S (uk) Опаковання
UA38438S (uk) Опаковання
UA38433S (uk) Опаковання